Biomedical Engineering Reference
In-Depth Information
Stremersch S, Van Dyck W (2009) Marketing of the life sciences: a new framework and research
agenda for a nascent field. J Mark 73(July):4-30
Terry NP (2010) Physicians and patients who “friend” or “tweet”: constructing a legal framework
for social networking in a highly regulated domain. Indiana Law Rev 43(2):285-341
The Economist (2007) Beyond the blockbuster: drugs firms are rethinking their business model.
http://www.economist.com/node/9409230
.
Accessed 17 Oct 2011
Vargo SL, Lusch RF (2004) Evolving to a new dominant logic for marketing. J Mark 68
(January):1-17
Venkataraman S, Stremersch S (2007) The debate on influencing doctors' decisions: are drug
characteristics the missing link? Manag Sci 53(11):1688-1701
Verhoef PC, Reinartz WJ, Krafft M (2010) Customer engagement as a new perspective in customer
management. J Serv Res 13(3):247-252
Verniers I, Stremersch S, Croux C (2011) The global entry of new pharmaceuticals: a joint inves-
tigation of launch window and price. International J Res Mark 28(4):(forthcoming)
Weintraub A (2007) The doctor won't see you now. BusinessWeek, 5 February
Wilkes MS, Bell RA, Kravitz RL (2000) Direct-to-consumer prescription drug advertising: trends,
impact, and implications. Health Aff 19(2):110
Wosinska M (2005) Direct-to-consumer advertising and drug therapy compliance. J Mark Res
42(August):323-332
Wright C (2010) The doctor won't see you (Mr. Pharma Rep), now. PR Newswire, May 6.
http://
92964699.html
.
Accessed 17 Jun 2013
Young HN, Bell RA, Epstein RM, Feldman MD, Kravitz RL (2008) Physicians' shared decision-
making behaviors in depression care. Arch Intern Med 168(13):1404-1408
Zerhouni E (2003) The NIH roadmap. Science 302(5642):63-72
Search WWH ::
Custom Search